IGF1R and myeloid sarcoma: Let-7i in circulating exosomes inhibits insulin like growth factor 1 receptor (IGF1R) and transforming growth factor beta receptor 1, thus inhibiting the differentiation of regulatory T cells and promoting the development of MS (Kimura et al., 2018).